Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Oncology Reports

Issue 9/2023

Content (10 Articles)

Vascular Inflammation, Cancer, and Cardiovascular Diseases

George S. Prousi, Amogh M. Joshi, Varun Atti, Daniel Addison, Sherry-Ann Brown, Avirup Guha, Brijesh Patel

Open Access Prostate Cancer

Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice

Janice Kim, Kendall Freeman, Alyssa Ayala, McKay Mullen, Zijie Sun, June-Wha Rhee

Open Access Cancer-Associated Venous Thrombosis

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism

Marta Masini, Matteo Toma, Paolo Spallarossa, Italo Porto, Pietro Ameri

Melanoma

Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma

Céline Boutros, Djaouida Belkadi-Sadou, Antoine Marchand, Séverine Roy, Emilie Routier, Caroline Robert

Melanoma

The Microbiome in Advanced Melanoma: Where Are We Now?

Dylan D. Fortman, Drew Hurd, Diwakar Davar

NSCLC

Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer

Alessandro Di Federico, Ilaria Ricciotti, Valentina Favorito, Sandra Vietti Michelina, Pietro Scaparone, Giulio Metro, Andrea De Giglio, Federica Pecci, Giuseppe Lamberti, Chiara Ambrogio, Biagio Ricciuti

Open Access Lymphedema

Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review

David Doubblestein, Elizabeth Campione, Julie Hunley, Mark Schaverien

Open Access Glioblastoma

The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies

Nicholas S. Cho, Weng Kee Wong, Phioanh L. Nghiemphu, Timothy F. Cloughesy, Benjamin M. Ellingson

Glioblastoma

Disease Assessments in Patients with Glioblastoma

Kester A. Phillips, David O. Kamson, David Schiff

Kidney Cancer

Kidney Cancer Integrative Oncology: Possible Options for Care

Samuel Mathis, Victor S. Sierpina

Aug 23
Issue: 8/2023
Oct 23
Issue: 10/2023

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits